HYB-AND-SEQ
DEAD

Serial Number

86500105

Owner

NanoString Technologies, Inc.

Attorney

Nathan E. Ferguson

Filing Date

Jan 9, 2015

Add to watchlist:

No watchlists yet
View on USPTO

HYB-AND-SEQ Trademark

Serial Number: 86500105

HYB-AND-SEQ is a trademark filed by NanoString Technologies, Inc. on January 9, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

NanoString Technologies, Inc. (31 trademarks)

530 Fairview Avenue North, Suite 2000
Seattle, WA 98109

Entity Type: 03

Trademark Details

Filing Date

January 9, 2015

Registration Date

Not Registered

Published for Opposition

August 25, 2015

Goods & Services

computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices in the nature of electronic analyzers for the transport and analysis of fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type comprising laboratory equipment for screening samples, detecting the presence of analytes in samples and identifying sample types, namely, containers, dishes, microscope slides, plastic bags, swabs, test tubes, vials and wipes for collecting, storing and transmitting samples and specimens; downloadable multimedia file containing diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications relating to scientific research

diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes

diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing

clinical and medical diagnostic instruments, namely, nucleic acid sequencers

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 26, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 26, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 5, 2018 EXRA
SOU EXTENSION 5 GRANTED
Apr 4, 2018 EX5G
SOU EXTENSION 5 FILED
Mar 30, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 30, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2017 EXRA
SOU EXTENSION 4 GRANTED
Oct 17, 2017 EX4G
SOU EXTENSION 4 FILED
Oct 17, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 17, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2017 EXRA
SOU EXTENSION 3 GRANTED
Mar 24, 2017 EX3G
SOU EXTENSION 3 FILED
Mar 24, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 24, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 8, 2016 EXRA
SOU EXTENSION 2 GRANTED
Nov 7, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 3, 2016 AITU
SOU EXTENSION 2 FILED
Oct 18, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 18, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2016 EXRA
SOU EXTENSION 1 GRANTED
Apr 18, 2016 EX1G
SOU EXTENSION 1 FILED
Apr 18, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 18, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 20, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 17, 2015 PREV
ASSIGNED TO LIE
Jul 17, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 1, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 1, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 1, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 1, 2015 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2015 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2015 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2015 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2015 NWOS
NEW APPLICATION ENTERED
Jan 13, 2015 NWAP